These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11205276)

  • 1. Encapsulation of vinblastine into new liposome formulations prepared from triticum (wheat germ) lipids and its activity against human leukemic cell lines.
    Maswadeh H; Hatziantoniou S; Demetzos C; Dimas K; Georgopoulos A; Rallis M
    Anticancer Res; 2000; 20(6B):4385-90. PubMed ID: 11205276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro.
    Maswadeh H; Demetzos C; Dimas K; Hatziantoniou S; Georgopoulos A; Rallis M; Dallas P; Papaioannou G
    Anticancer Res; 2001; 21(4A):2577-83. PubMed ID: 11724324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro cytotoxic/cytostatic activity of anionic liposomes containing vinblastine against leukaemic human cell lines.
    Maswadeh H; Demetzos C; Dimas K; Loukas YL; Georgopoulos A; Mavromoustakos T; Papaioannou GT
    J Pharm Pharmacol; 2002 Feb; 54(2):189-96. PubMed ID: 11848282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate.
    Zhang H; Wang ZY; Gong W; Li ZP; Mei XG; Lv WL
    Int J Pharm; 2011 Jul; 414(1-2):56-62. PubMed ID: 21596128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology.
    Li CL; Cui JX; Wang CX; Zhang L; Li YH; Zhang L; Xiu X; Li YF; Wei N
    Int J Pharm; 2010 May; 391(1-2):230-6. PubMed ID: 20214962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
    Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
    Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines.
    Papagiannaros A; Hatziantoniou S; Dimas K; Papaioannou GT; Demetzos C
    Biomed Pharmacother; 2006 Jan; 60(1):36-42. PubMed ID: 16271845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines.
    Papagiannaros A; Dimas K; Papaioannou GT; Demetzos C
    Int J Pharm; 2005 Sep; 302(1-2):29-38. PubMed ID: 16099117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
    Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
    J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
    Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
    J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and biological analysis of liposomal formulations of vincristine.
    Waterhouse DN; Madden TD; Cullis PR; Bally MB; Mayer LD; Webb MS
    Methods Enzymol; 2005; 391():40-57. PubMed ID: 15721373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method of simultaneous analysis of liposome components using HPTLC/FID.
    Hatziantoniou S; Demetzos C
    Methods Mol Biol; 2010; 606():363-8. PubMed ID: 20013408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
    Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
    J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines.
    Goniotaki M; Hatziantoniou S; Dimas K; Wagner M; Demetzos C
    J Pharm Pharmacol; 2004 Oct; 56(10):1217-24. PubMed ID: 15482635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
    You J; Wan F; de Cui F; Sun Y; Du YZ; Hu FQ
    Int J Pharm; 2007 Oct; 343(1-2):270-6. PubMed ID: 17706383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.